PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses
Clinical trial NCT07739537 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07739537
- Sponsor
- Massachusetts General Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2029-09-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.